Bill > HR3851

This bill extends and expands several provisions related to the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, which help small businesses engage in federal research and development. Specifically, the bill extends the "Direct to Phase II" authority through fiscal year 2030, allowing federal agencies to award grants directly to promising small businesses for the second phase of research without requiring them to complete the first phase. The bill limits these direct awards to 10% of total SBIR program funds for most agencies, with the National Institutes of Health (NIH) allowed up to 15%. The legislation also extends the Commercialization Readiness Program for civilian agencies through fiscal year 2030, modifying some terminology from "pilot program" to "covered program". Additionally, the bill extends two pilot programs: the Phase 0 Proof of Concept Partnership Program and the Commercialization Assistance Pilot Programs, both of which will now continue through September 30, 2030. These extensions aim to provide continued support and flexibility for small businesses developing innovative technologies with potential commercial and governmental applications.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/3851/all-info